๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Transoral vertebral augmentation with polymethylmethacrylate in the treatment of a patient with a dens fracture nonunion and subarticular vertebral body fracture of C2

โœ Scribed by Douglas P. Beall; Matthew Stanfield; Hal D. Martin; Annette M. Stapp


Publisher
Springer
Year
2007
Tongue
English
Weight
262 KB
Volume
36
Category
Article
ISSN
0364-2348

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Matched-cohort study of body composition
โœ Jamie H. Macdonald; Sally F. Evans; Helen L. Davies; Sally Wilson; Michael W. J. ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 2 views

## Abstract ## Objective To determine the effect of 6 years of routine management on body composition, physical functioning, and quality of life, and their interrelationships, in men with idiopathic vertebral fracture. ## Methods Twenty men with idiopathic vertebral fracture (patients: mean ยฑ SD

Efficacy of continued alendronate for fr
โœ Ann V Schwartz; Douglas C Bauer; Steven R Cummings; Jane A Cauley; Kristine E En ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› American Society for Bone and Mineral Research ๐ŸŒ English โš– 102 KB

## Abstract In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. Continuing ALN reduced the risk of clinical but not morphometric vertebral fractu